Literature DB >> 3905256

Positron emission tomography.

A A Lammertsma, R S Frackowiak.   

Abstract

Positron computed tomography allows for the in vivo measurement of the regional tissue concentration of positron-emitting radionuclides such as 15O, 11C, 13N, and 18F. By using different tracers, a variety of metabolic processes can be quantitated. These include blood flow, oxygen utilization, glucose utilization, amino acid transport, blood volume, cation exchange, pH, and others. This review will contain three sections. First, the principles of positron computed tomography and the progress in instrumentation will be discussed. Second, tracer models will be analyzed. These models are vital in the extraction of physiological data from the measurements of activity. Finally, clinical studies will be evaluated in terms of new pathophysiological information obtained.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3905256

Source DB:  PubMed          Journal:  Crit Rev Biomed Eng        ISSN: 0278-940X


  5 in total

1.  Positron emission tomography.

Authors:  A A Lammertsma
Journal:  Brain Topogr       Date:  1992       Impact factor: 3.020

Review 2.  Positron emission tomography and in vivo measurements of tumour perfusion and oxygen utilisation.

Authors:  A A Lammertsma
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 3.  Hypoxia imaging-directed radiation treatment planning.

Authors:  J G Rajendran; K R G Hendrickson; A M Spence; M Muzi; K A Krohn; D A Mankoff
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07       Impact factor: 9.236

4.  In vivo measurements of blood flow and bone metabolism in osteoarthritis.

Authors:  Olivier P P Temmerman; Pieter G H M Raijmakers; Reina Kloet; Gerrit J J Teule; Ide C Heyligers; Adriaan A Lammertsma
Journal:  Rheumatol Int       Date:  2012-07-26       Impact factor: 2.631

5.  Bone metabolism after total hip revision surgery with impacted grafting: evaluation using H2 15O and [18F]fluoride PET; a pilot study.

Authors:  Olivier P P Temmerman; Pieter G H M Raijmakers; Ide C Heyligers; Emile F I Comans; Mark Lubberink; Gerrit J J Teule; Adriaan A Lammertsma
Journal:  Mol Imaging Biol       Date:  2008-06-10       Impact factor: 3.488

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.